NCT07202026
Prescription Opioid Discontinuation: Honoring Patient Insights and Experience to Support Safe and Caring Transitions -- Decision Aid Pilot
Enrolling by Invitation
NAAges 18+InterventionalHealth servicesKaiser PermanenteInvestigator-initiated
~30 participants
Updated 2025-11-05 on ClinicalTrials.gov
What's tested:Patient-centered Decision Aid to support long-term opioid therapy tapering
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Acceptability of DA
Measured over 1-2 weeks
Conditions
Where it's being run
1 sites across 1 statesWashington1
Study leadership
- Clarissa W Hsu, PhD · PRINCIPAL_INVESTIGATOR · Kaiser Permanente
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
age 18 or older
LTOT in the past 18 months (LTOT is ≥60 days of ≥50 MEDs day in each of 2 consecutive 90-day periods with medication treatment for OUD excluded)
Have been taking opioids for chronic pain for at least 6 months
Able to speak and read English
Exclusion
cancer diagnosis in the last 5 years (excluding non-melanoma skin cancers)
current palliative or hospice care
cognitive disability
psychiatric hospitalization in the last year
surgery in the last 6 months
current residence in an inpatient rehabilitation or skilled nursing facility
What this trial measures
- Acceptability of DA1-2 weeks
We will use Matlock et al.'s acceptability ranking scale to assess the acceptability of the DA to patients